Compare Align Technology, Inc. (ALGN) vs MakeMyTrip Ltd (MMYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs MakeMyTrip Ltd — how do they compare? Align Technology, Inc. trades at $181.51 (market cap $12.86B), while MakeMyTrip Ltd trades at $57.19 (market cap $5.56B). The key difference: Align Technology, Inc. is far larger — about 2.3× MakeMyTrip Ltd's market cap, and Align Technology, Inc. is trading nearer its 52-week high, MakeMyTrip Ltd nearer its low. Which is the better fit depends on your goals.
| ALGN | MMYT | |
|---|---|---|
Market Cap | $12.86B | $5.56B |
Sector | Health | Technology |
52-Week High | $207.19 | $103.21 |
52-Week Low | $124.88 | $36.30 |
Enterprise Value | $11.92B | $6.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
MMYT trades at $58.62, up 1.03% today, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.25 exceeding expectations. Revenue reached $978.34 million in 2025, though net income margin is projected to narrow to 4.96% in 2026. Analyst consensus is strongly positive with 72.73% buy ratings. Recent news highlights temporary travel disruptions but maintains confidence in long-term growth.
The outlook remains favorable given consistent earnings outperformance and robust analyst support, but risks include projected margin compression and rising debt levels. Investors should weigh strong operational cash flow against potential volatility from travel industry headwinds and increasing liabilities in the coming year.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →
